A detailed history of Laidlaw Wealth Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Laidlaw Wealth Management LLC holds 703 shares of VRTX stock, worth $353,222. This represents 0.19% of its overall portfolio holdings.

Number of Shares
703
Previous 703 -0.0%
Holding current value
$353,222
Previous $293,000 12.29%
% of portfolio
0.19%
Previous 0.17%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$407.69 - $446.08 $213,221 - $233,299
-523 Reduced 42.66%
703 $293,000
Q4 2023

Feb 12, 2024

BUY
$343.0 - $410.68 $420,518 - $503,493
1,226 New
1,226 $498,000
Q2 2023

Aug 11, 2023

BUY
$314.42 - $351.91 $11,633 - $13,020
37 Added 3.57%
1,072 $377,000
Q1 2023

May 12, 2023

SELL
$283.23 - $323.1 $11,329 - $12,924
-40 Reduced 3.72%
1,035 $326,000
Q4 2022

Feb 14, 2023

BUY
$285.76 - $321.48 $36,291 - $40,827
127 Added 13.4%
1,075 $310,000
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $58,599 - $65,383
214 Added 29.16%
948 $274,000
Q2 2022

Aug 12, 2022

SELL
$234.96 - $292.55 $32,894 - $40,957
-140 Reduced 16.02%
734 $207,000
Q1 2022

May 12, 2022

BUY
$221.42 - $260.97 $193,521 - $228,087
874 New
874 $228,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Laidlaw Wealth Management LLC Portfolio

Follow Laidlaw Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laidlaw Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Laidlaw Wealth Management LLC with notifications on news.